Discontinued — last reported Q3 '25
Operating
Impairment Charges
Amgen Impairment Charges decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $800.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2014
Last reportedQ3 2025
How to read this metric
An increase signals potential operational issues, poor past investment decisions, or adverse market conditions for specific business units.
Detailed definition
These are non-cash charges recorded when the carrying value of an asset exceeds its fair market value. They indicate tha...
Peer comparison
Often seen during restructuring or economic downturns across industrial sectors.
Metric ID:
impairment_charges_cfHistorical Data
13 periods
| Q3 '21 | Q4 '21 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $5.00M | $2.00M | $0.00 | $851.00M | $68.00M | $0.00 | $61.00M | $30.00M | $800.00M | $400.00M | $0.00 |
| QoQ Change | — | — | — | -60.0% | -100.0% | — | -92.0% | -100.0% | — | -50.8% | >999% | -50.0% | -100.0% |
| YoY Change | — | — | — | — | -100.0% | >999% | — | — | — | -96.5% | >999% | +555.7% | -100.0% |
Range$0.00 – $851.00M
Avg YoY Growth>999%
Median YoY Growth+229.6%
Current Streak2 quarters decline
Impairment Charges at Other Companies
Frequently Asked Questions
- What is Amgen's impairment charges?
- Amgen (AMGN) reported impairment charges of $0.00 in Q1 2026.
- How has Amgen's impairment charges changed year-over-year?
- Amgen's impairment charges decreased by 100.0% year-over-year, from $800.00M to $0.00.
- What does impairment charges mean?
- A write-down of an asset's value because it is worth less than what is recorded on the balance sheet.